Patents by Inventor Katherine Griffiths

Katherine Griffiths has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of treating or reducing the risk of fibrosis and cancer
    Patent number: 11142588
    Abstract: The present disclosure relates to polypeptides (also referred to herein as CXCR4 binding molecules or polypeptides) that are directed against the G-coupled protein receptor CXCR4, also known as Fusin or CD184. The invention also relates to nucleic acids encoding such polypeptides; to methods for preparing such polypeptide; to compositions, and in particular to pharmaceutical compositions that comprise such polypeptides and to uses of such polypeptides for therapeutic or diagnostic purposes.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: October 12, 2021
    Assignee: ADALTA LIMITED
    Inventors: Michael Foley, Andrew Pow, Katherine Griffiths, Samantha Cobb, Katerina Viduka
  • CXCR4 BINDING MOLECULES
    Publication number: 20200231708
    Abstract: The present disclosure relates to polypeptides (also referred to herein as CXCR4 binding molecules or polypeptides) that are directed against the G-coupled protein receptor CXCR4, also known as Fusin or CD184. The invention also relates to nucleic acids encoding such polypeptides; to methods for preparing such polypeptide; to compositions, and in particular to pharmaceutical compositions that comprise such polypeptides and to uses of such polypeptides for therapeutic or diagnostic purposes.
    Type: Application
    Filed: December 18, 2019
    Publication date: July 23, 2020
    Inventors: Michael Foley, Andrew Pow, Katherine Griffiths, Samantha Cobb, Katerina Viduka
  • CXCR4 binding molecules and methods of use thereof
    Patent number: 10538596
    Abstract: The present disclosure relates to polypeptides (also referred to herein as CXCR4 binding molecules or polypeptides) that are directed against the G-coupled protein receptor CXCR4, also known as Fusin or CD184. The invention also relates to nucleic acids encoding such polypeptides; to methods for preparing such polypeptide; to compositions, and in particular to pharmaceutical compositions that comprise such polypeptides and to uses of such polypeptides for therapeutic or diagnostic purposes.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: January 21, 2020
    Assignee: Adalta Limited
    Inventors: Michael Foley, Andrew Pow, Katherine Griffiths, Samantha Cobb, Katerina Viduka
  • CXCR4 BINDING MOLECULES
    Publication number: 20180072816
    Abstract: The present disclosure relates to polypeptides (also referred to herein as CXCR4 binding molecules or polypeptides) that are directed against the G-coupled protein receptor CXCR4, also known as Fusin or CD184. The invention also relates to nucleic acids encoding such polypeptides; to methods for preparing such polypeptide; to compositions, and in particular to pharmaceutical compositions that comprise such polypeptides and to uses of such polypeptides for therapeutic or diagnostic purposes.
    Type: Application
    Filed: January 8, 2016
    Publication date: March 15, 2018
    Inventors: Michael Foley, Andrew Pow, Katherine Griffiths, Samantha Cobb, Katerina Viduka
  • DNA POLYMERASES AND MUTANTS THEREOF
    Publication number: 20160108381
    Abstract: The present invention provides polypeptides having a nucleotide polymerase activity and method of enhancing polymerase activity. The polypeptides of the present invention may possess both a DNA-dependent DNA polymerase activity and an RNA-dependent DNA polymerase activity, i.e., a reverse transcriptase activity. The polypeptides of the present invention may be used in any application including, but not limited to, DNA sequencing reactions, amplification reactions, cDNA synthesis reactions, and combined cDNA synthesis and amplification reactions, e.g., RT-PCR.
    Type: Application
    Filed: October 5, 2015
    Publication date: April 21, 2016
    Inventors: Jun LEE, Gary Gerard, Harini Shandilya, Katherine Griffiths, Moreland Gibbs, Peter Bergquist, Robert Potter
  • DNA Polymerases and mutants thereof
    Publication number: 20070020622
    Abstract: The present invention provides polypeptides having a nucleotide polymerase activity and method of enhancing polymerase activity. The polypeptides of the present invention may posses both a DNA-dependent DNA polymerase activity and an RNA-dependent DNA polymerase activity, i.e., a reverse transcriptase activity. The polypeptides of the present invention may be used in any application including, but not limited to, DNA sequencing reactions, amplification reactions, cDNA synthesis reactions, and combined cDNA synthesis and amplification reactions, e.g., RT-PCR.
    Type: Application
    Filed: September 16, 2002
    Publication date: January 25, 2007
    Inventors: Jun Lee, Gary Gerard, Harini Shandilya, Katherine Griffiths, Moreland Gibbs, Peter Bergquist, Robert Potter
  • Thermococcus zilligii DNA polymerases and variants thereof
    Publication number: 20070009924
    Abstract: Native and variant Thermococcus zilligii DNA polymerases are disclosed, as are methods for using the same for nucleic acid synthesis, DNA sequencing, nucleic acid amplification and cDNA synthesis.
    Type: Application
    Filed: January 30, 2006
    Publication date: January 11, 2007
    Inventors: Jun Lee, Kyusung Park, Katherine Griffiths, Moreland Gibbs, Peter Bergquist